glp-1 cause diarrhea Side Effects: A Complete Guide to What You Can Expect GLP-1 Diarrhea: Causes, Treatment &

About 10% of participants on the highest dose discontinued treatment due to their adverse events, compared to 5% of those on placebo

The least-squares mean percentage change in body weight at 24 weeks in the retatrutide groups was 7.2% in the 1 mg group, and up to 17.5% in the 12 mg group, as compared with 1.6% in the placebo group

Journal of Dental Research, 95 (12), 13331340

Splitting, chewing, or crushing the tablet also breaks down this barrier, making the drug less effective

The injectable GLP-1 medications currently on the market have published higher average weight loss figures in their landmark trials: Semaglutide (Wegovy): Demonstrated approximately 14.9% average body weight reduction in the STEP 1 trial